Current judgments regarding COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases

The author reviews the current attitudes to vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases. Most experts admit theneed in vaccination, although data on its effectiveness and safety in patients with autoimmune inflammatory rheumatic diseases are limited, since such patients were not enrolled in phase I-III clinical trials. Vaccination is a cornerstone in the fight against the COVID-19 pandemic, althogh it cannot completely prevent SARS-CoV-2 infection. Therefore, vaccinated patients with autoimmune inflammatory rheumatic diseases should adhere to all measures that reduce the risk of infection, including wearing a mask, hand hygiene and social distancing.

Key words

Vaccination, COVID-19, autoimmune inflammatory rheumatic diseases, DMARDs, biologics